Sertraline v placebo for sertraline responders with post-traumatic stress disorder†

Outcomes at 28 weeksSertralinePlaceboRRR (95% CI)NNT (CI)
†Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article.
Relapse5.3%26%80% (27 to 95)5 (3 to 19)
Relapse or discontinuation because of clinical deterioration16%46%65% (27 to 85)3 (2 to 10)
Acute exacerbation16%52%70% (37 to 86)3 (2 to 7)
Did not complete study39%60%35% (1.7 to 58)5 (3 to 135)